Cargando…
Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
PURPOSE: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). MATERIALS AND METHODS: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were trea...
Autores principales: | Al-Amri, Abdulrahman Mohammed, Fiorentini, Sandra Flavia, Albarry, Maan A., Bamahfouz, Ashjan Yousef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657154/ https://www.ncbi.nlm.nih.gov/pubmed/29118487 http://dx.doi.org/10.4103/ojo.OJO_232_2014 |
Ejemplares similares
-
Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019) -
Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis
por: Al-Amri, Abdulrahman M., et al.
Publicado: (2016) -
Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus
ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023) -
Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis
por: Albarry, Maan Abdullah, et al.
Publicado: (2022) -
Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)